首页> 外国专利> METHOD FOR EVALUATING NUCLEAR FACTOR KAPPA-B INDUCING FACTOR (NFIF) MODULATING ACTIVITY

METHOD FOR EVALUATING NUCLEAR FACTOR KAPPA-B INDUCING FACTOR (NFIF) MODULATING ACTIVITY

机译:核因子KAPPA-B诱导因子(NFIF)调节活性的评估方法

摘要

The present invention is directed to nuclear factor kB (NFkB)-inducing factor polypeptides (NFIF polypeptides) which are capable of inducing NKkB. The present invention includes within its scope NFIF polypeptides, including NFIF-14b and NFIF-7a, DNA, including cDNA, encoding these polypeptides, and expression vectors capable of expressing NFIF polypeptides. Also included are methods and compositions for increasing NFkB induction in a patient, methods and compositions for lowering NFkB induction in a patient, methods for inhibiting inflammation, and methods for manufacture of a medicament intended for the treament and/or prevention of an NFkB-regulated inflammatory response. In addition, methods for determining whether a test compound inhibits or enhances the activity of NFIF polypeptides are provided.
机译:本发明涉及能够诱导NKkB的核因子kB(NFkB)诱导因子多肽(NFIF多肽)。本发明在其范围内包括NFIF多肽,包括NFIF-14b和NFIF-7a,DNA,包括编码这些多肽的cDNA,以及能够表达NFIF多肽的表达载体。还包括用于增加患者中NFkB诱导的方法和组合物,用于降低患者中NFkB诱导的方法和组合物,用于抑制炎症的方法以及用于治疗和/或预防NFkB调节的药物的制备方法。炎症反应。另外,提供了确定测试化合物是否抑制或增强NFIF多肽活性的方法。

著录项

  • 公开/公告号IL198132B

    专利类型

  • 公开/公告日2012-08-30

    原文格式PDF

  • 申请/专利权人 AVENTIS PHARMACEUTICALS INC.;

    申请/专利号IL198132

  • 发明设计人

    申请日2009-04-16

  • 分类号C12N15/09;A61K31/7088;A61K35/76;A61K38/00;A61K39/395;A61K45/00;A61K48/00;A61P9/10;A61P29/00;A61P37/02;A61P43/00;C07Knull/null;C07K14/47;C12Q1/68;

  • 国家 IL

  • 入库时间 2022-08-21 17:24:44

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号